Morgan O’Shea
Director of Medicinal Chemistry Larkspur Biosciences
Seminars
Wednesday 29th October 2025
Preclinical Evaluation of Lipid Kinase PIP4K2C Degrader, LRK-4189 for the Treatment of Oncology Indications
12:00 pm
